Delivery Order SPE2DB24D3013-SPE2DB25FFQJF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,055.05 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product...
- The Defense Logistics Agency awarded a $22,497.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for TALTZ 80 mg/ml autoinjector supply. This is a firm fixed price, non-set-aside contract with a completion date of August 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a delivery order valued at $21,929.06 to AmerisourceBergen Drug Corp for the supply of TALTZ 80 MG/ML Autoinjector, with an ultimate completion date of July 25, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a single delivery order transaction. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of TALTZ 80 mg/ml auto-injector (2-pack) with a ceiling value of $9,029.13 under a firm fixed-price contract type. This award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999.9 million through December 2026. The contract was competitively awarded with no...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,228.37 on August 11, 2025, for the supply of TALTZ 80 MG/ML AutoInjector (2-pack). This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 12, 2025, with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract utilizes no set-aside provisions and represents a routine pharmaceutical procurement through established federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,660.30 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Autoinjector on September 3, 2025, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector medication, valued at $37,608.74 under a firm fixed-price contract type. The award was issued on September 9, 2025, with an ultimate completion date of September 10, 2025, and represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a $22,134.58 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 9, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of TALTZ 80 mg/ml auto-injector medication. This non-set-aside, competitively awarded contract carries a ceiling value of $6,641.24 under a firm fixed price arrangement, with an ultimate completion date of August 19, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which...
- The Defense Logistics Agency awarded a $11,239.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector (2-pack) pharmaceutical supplies. The contract, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQJFDelivery Order
The Defense Logistics Agency awarded a $3,346.05 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector on September 9, 2025, with completion targeted for September 10, 2025. This competitively awarded, firm fixed-price contract represents a pediatric delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across military and veteran healthcare systems. The delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply portfolio with the Defense Logistics Agency's Medical Supply Chain, which includes specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. As the prime contractor on this delivery order, AmerisourceBergen leverages its extensive federal contracting experience and the DLA's global pharmaceutical support framework to fulfill military healthcare requirements. The contract structure demonstrates the company's capability to meet federal procurement standards through open competition, consistent with DLA's strategy to establish multiple pharmaceutical prime vendor contracts across different regions to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 9/9/25 |